上海联影医疗科技股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议召开时间：2025 年 11 月 11 日（星期二）下午 15:00-16:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 证券代码： 688271 证券简称： 联影医疗 公告编号： 2025-044 3、会议召开方式：上证路演中心网络互动 三、参会人员 公司董事长兼联席首席执行官张强先生；董事、总经理兼联席首席执行官 GUOSHENG TAN 先生；董事、董事会秘书兼首席投资官 TAO CAI 先生；财务负责 人兼首席财务官王建保先生；独立董事王少飞先生（如遇特殊情况，参会人员可 能进行调整）。 投资者可于 2025 年 11 月 4 日（星期二）至 11 月 10 日(星期一)16:00 前 登录上证路演中心网站首页点击"提问预 ...

免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每经头条（nbdtoutiao）——A股突破4000点！十年沉寂终迎爆发，科技主线重塑市场，"慢牛"新格局开 启！ 每日经济新闻 每经AI快讯，联影医疗（SH 688271，收盘价：146.56元）10月29日晚间发布三季度业绩公告称，2025 年前三季度营收约88.59亿元，同比增加27.39%；归属于上市公司股东的净利润约11.2亿元，同比增加 66.91%；基本每股收益1.36元，同比增加65.85%。 （记者 王晓波） 截至发稿，联影医疗市值为1208亿元。 ...

上海联影医疗科技股份有限公司 2025 年第三季度报告 □是 √否 一、主要财务数据 证券代码：688271 证券简称：联影医疗 上海联影医疗科技股份有限公司 2025 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会及董事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假记载、误 导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人张强、主管会计工作负责人王建保及会计机构负责人（会计主管人员）李萍保证季度 报告中财务信息的真实、准确、完整。 第三季度财务报表是否经审计 （一） 主要会计数据和财务指标 1 / 12 单位：元 币种：人民币 项目 本报告期 本报告期比 上年同期增 减变动幅度 (%) 年初至报告期末 年初至报告 期末比上年 同期增减变 动幅度(%) 营业收入 2,843,014,990.57 75.41 8,858,916,392.73 27.39 利润总额 105,580,595.53 不适用 1,178,552,726.27 65.56 归属于上 ...

格隆汇10月29日｜联影医疗(688271.SH)发布2025年第三季度报告，第三季度营收为28.43亿元，同比增 长75.41%；净利润为1.22亿元，同比扭亏为盈。前三季度营收为88.59亿元，同比增长27.39%；归属于 上市公司股东的净利润为11.20亿元，同比增长66.91%。业绩增长主要受益于国内市场行业政策落地节 奏加快以及公司海外业务稳步增长。 ...

联影医疗(688271.SH)公告称，公司发布2025年第三季度报告，第三季度营收为28.43亿元，同比增长 75.41%；净利润为1.22亿元，同比扭亏为盈。前三季度营收为88.59亿元，同比增长27.39%；归属于上 市公司股东的净利润为11.20亿元，同比增长66.91%。 ...

每日经济新闻 每经AI快讯，10月29日，联影医疗(688271.SH)公告称，公司发布2025年第三季度报告，第三季度营收 为28.43亿元，同比增长75.41%；净利润为1.22亿元，同比扭亏为盈。前三季度营收为88.59亿元，同比 增长27.39%；归属于上市公司股东的净利润为11.20亿元，同比增长66.91%。业绩增长主要受益于国内 市场行业政策落地节奏加快以及公司海外业务稳步增长。 ...

Core Points - The company announced that it will hold a workers' representative meeting on October 27, 2025, to elect Wei Qiang as the employee representative director of the fifth board of directors [1] Company Summary - The company is set to convene a workers' representative meeting on October 27, 2025 [1] - Wei Qiang has been nominated for the position of employee representative director on the fifth board of directors [1]

Core Viewpoint - The report emphasizes that China's modernization relies on technological advancement, highlighting the importance of original innovation and the integration of technology and industry to achieve high-level self-reliance in technology [1] Group 1: Technological Innovation and Industry Integration - The "14th Five-Year Plan" outlines the need for deep integration of technological innovation and industrial innovation, with a focus on addressing "bottleneck" issues in high-end chips and industrial software [1][2] - The government is encouraged to transform specific industry challenges into national technology tasks, thereby supporting enterprises in overcoming technological barriers [2][3] Group 2: Role of Enterprises in Innovation - Enterprises are identified as the main body of technological innovation, with a call for vertical integration strategies to address complex interdisciplinary challenges [3][11] - The importance of fostering a collaborative environment between enterprises and research institutions is highlighted, allowing for timely solutions to innovation challenges [5][10] Group 3: Government's Role in Supporting Innovation - The government should act as a market rule designer and key buyer, creating a long-term vision for industry participants and breaking down information barriers [5][12] - A shift from reactive support to proactive engagement with leading enterprises and scientists is recommended to better understand future industrial development directions [4][15] Group 4: AI and Industrial Applications - The report discusses the significance of artificial intelligence (AI) in driving industrial innovation, with examples of successful applications in companies like Zhejiang University Control [13][14] - The relationship between traditional industrial enterprises and AI companies is crucial, as traditional firms provide the operational context and data necessary for AI development [15][19] Group 5: Challenges in Basic Research and Industry Needs - The need for a strategic, forward-looking, and systematic approach to basic research is emphasized, ensuring alignment with industrial demands [16][20] - The report suggests that universities and research institutions must equally value both vertical and horizontal projects to effectively serve industry innovation needs [20][21] Group 6: Non-linear Relationship Between Science, Technology, and Industry - Innovation is characterized as a practical process, where the development of technology is driven by industrial needs and experiences [25][27] - The report provides examples from the dairy and agricultural sectors to illustrate how industry-driven research can lead to significant technological advancements [22][24]

Core Insights - The article emphasizes the importance of achieving autonomy in high-end medical equipment for national healthcare security and public health welfare [1] - It highlights China's transition from being a "follower" to a "leader" in high-end medical imaging technology, particularly in MRI systems [3][6] Group 1: Breakthroughs in MRI Technology - China has successfully developed and industrialized 3.0T high-field MRI equipment, breaking the foreign monopoly in this sector [2] - The first 3.0T high-field MRI device was launched by Shanghai United Imaging Healthcare Co., Ltd. in 2015, making China the third country to master the entire technology chain for high-field MRI after the USA and Germany [2] - The launch of the world's first 5.0T ultra-high-field MRI system in 2022 marked a significant leap for China, filling a 20-year international gap in ultra-high-field MRI technology [3] Group 2: Technological Innovations and Collaborations - The 5.0T MRI system features a resolution of 200 micrometers, significantly improving early diagnosis accuracy for conditions like tumors and neurodegenerative diseases [3] - The collaboration between the National Key Laboratory of Medical Imaging Science and Technology and United Imaging Healthcare has led to the development of 72 intellectual property rights, including 9 patents in the USA [3] - The introduction of the LIVE Imaging technology allows for dynamic imaging, enhancing the observation and diagnosis of human movement [4] Group 3: Future Directions and Innovations - The research team led by Zheng Hairong is exploring cutting-edge medical technology theories, including non-invasive ultrasound deep brain stimulation and brain-machine interface technologies [5][6] - The goal is to establish global standards for medical equipment, with some technologies already reaching international leading levels [6] - The evolution from imitation to independent innovation has positioned China as a significant player in the global medical equipment market [6]

Group 1 - The core point of the article highlights the performance of the Sci-Tech Innovation ETF (588050), which opened down 0.85% at 1.510 yuan on October 28 [1] - Major holdings in the ETF include companies like SMIC, which fell by 1.12%, and Cambrian, which dropped by 1.68%, while Kingsoft Office saw an increase of 4.42% [1] - The ETF's performance benchmark is the Shanghai Stock Exchange Sci-Tech Innovation Board 50 Index, managed by ICBC Credit Suisse Asset Management Company, with a return of 6.10% since its inception on September 28, 2020, and a return of 2.28% over the past month [1]